Exosomes and polynucleotides represent the aesthetic industry's move toward regenerative, cell-signalling-based therapies, distinct from the mechanical or biostimulatory logic of Modules 3 and 4. This module frames both categories critically, since regulatory and evidentiary maturity here lags considerably behind established filler science.
What exosomes are
Exosomes are nanoscale extracellular vesicles (roughly 30–150 nanometres) secreted by cells, carrying proteins, lipids, and genetic material (mRNA, microRNA) that can influence the behaviour of recipient cells. In regenerative medicine research generally, exosomes are of interest because they appear to mediate much of the paracrine signalling effect historically attributed to whole stem-cell therapies, without the regulatory and safety complexity of transplanting live cells.
Sourcing and the regulatory grey zone
Cosmetic exosome products marketed for topical or intradermal aesthetic use are most commonly derived from plant sources or from cultured human/animal stem cells (commonly adipose- or umbilical-cord-derived). This is a critical teaching point: in several major jurisdictions, including the United States, regulators have issued explicit warnings about unapproved exosome products marketed for aesthetic and regenerative use, given concerns about sourcing, sterility, and unsubstantiated efficacy claims. Students should learn to treat 'exosome' as a category label requiring scrutiny of the specific product's sourcing, purification method, and regulatory status — not as a self-evidently validated therapeutic class.
Polynucleotides: a more established regulatory position
Polynucleotides, by contrast, have a longer clinical history (originating in wound-healing and ophthalmic applications before their aesthetic use developed) and, in the EU, several formulations carry CE marking as medical devices under the MDR framework discussed in Module 1. Purified salmon- or trout-derived DNA fragments are the dominant source, chosen partly because their fragment length and purification profile can be tightly controlled and standardised — a manufacturing consistency advantage relative to many exosome preparations.
Teaching the evidence hierarchy
For this module, the most valuable skill to build in students is not memorising product claims but applying a consistent evidentiary hierarchy: peer-reviewed randomised controlled trials, above cohort or case-series studies, above manufacturer-sponsored white papers, above testimonial or social-media-driven claims. Given how fast this category is evolving, the specific products in favour will change well within a student's career; the critical-appraisal skill will not.